SDGR

Schrodinger Inc
NASDAQHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$1.23B
P/E Ratio
EPS
$-1.36
Beta
1.62
52W High
$23.75
52W Low
$10.95
50-Day MA
$14.12
200-Day MA
$15.64
Dividend Yield
Profit Margin
-40.60%
Forward P/E
PEG Ratio

About Schrodinger Inc

Schrdinger, Inc. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. The company is headquartered in New York, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$254.91M
Gross Profit (TTM)$141.04M
EBITDA$-158.89M
Operating Margin-83.30%
Return on Equity-30.10%
Return on Assets-15.00%
Revenue/Share (TTM)$3.46
Book Value$4.21
Price-to-Book4.02
Price-to-Sales (TTM)4.83
EV/Revenue3.803
EV/EBITDA-10.82
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-1.60%
Shares Outstanding$65.56M
Float$57.65M
% Insiders3.01%
% Institutions97.99%

Historical Volatility

HV 10-Day
59.26%
HV 20-Day
48.73%
HV 30-Day
62.33%
HV 60-Day
57.06%
HV Rank
80.6%

Volatility is currently contracting

Analyst Ratings

Consensus ($20.57 target)
6
Buy
2
Hold

Latest News

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on June 12, 2026, the company granted restricted stock units (RSUs) with respect to 10,771 shares of the company's common stock to seven newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company's board of directors, and were made as a material inducement.

Business Wire6/18/2026Neutral
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on May 18, 2026, the company granted (i) a non-statutory stock option to purchase 1,875 shares of the company's common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 18,766 shares of the company's common stock to seven newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of.

Business Wire5/22/2026Neutral
Schrödinger to Participate in Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in May: BofA Securities 2026 Healthcare Conference: Fireside chat on Wednesday, May 13, 2026, at 5:20 p.m. E.T. RBC 2026 Global Healthcare Conference: Fireside chat on Tuesday, May 19, 2026 at 2:05 p.m. E.T. The live discussions can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the eve.

Business Wire5/4/2026Neutral
Schrödinger to Announce First Quarter 2026 Financial Results on May 5

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its first quarter 2026 financial results on Tuesday, May 5, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which.

Business Wire4/21/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026